MedTrace Logo

Treatment of Peri-implantitis Lesions by Using Biomaterial

NCT02375750 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2019-02-25

No results posted yet for this study

Summary

The primary objective of the study is to proof the successful use of Geistlich Bio-Oss® and Geistlich Bio-Gide® (already registered medical devices) in bony peri-implant defects due to peri-implantitis disease.

Conditions

  • Peri-implantitis

Interventions

DEVICE

GBO and GBG

Application of GBO and GBG to the defect fill after removal of chronic inflammatory tissue and decontamination of the surface of implant

OTHER

Standard treatment

Removal of chronic inflammatory tissue using titanium curettes and a rotary titanium brush; Implant Surface decontamination and closure by suturing

Sponsors & Collaborators

  • Geistlich Pharma AG

    lead INDUSTRY

Principal Investigators

  • Stefan Renvert, Professor · Department of Health Sciences, Kristianstad University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2017-02-28
Completion
2017-04-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02375750 on ClinicalTrials.gov